ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

Senate Bill Includes $10 Billion for NIH

February 6, 2009

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982